We are live on
!
Find out more
NL
Navalign LLC Portfolio holdings
AUM
$429M
1-Year Est. Return
18.12%
This Quarter
Est. Return
+2.25%
1 Year Est. Return
+18.12%
3 Year Est. Return
+50.7%
5 Year Est. Return
+57.4%
10 Year Est. Return
–
AUM
$407M
AUM Growth
+$28.4M
(+7.5%)
Cap. Flow
+$21.5M
Cap. Flow
% of AUM
5.27%
Top 10 Holdings %
Top 10 Hldgs %
52.74%
Holding
512
New
387
Increased
60
Reduced
39
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan US Quality Factor ETF
JQUA
|
+$7.59M |
| 2 |
Fidelity Total Bond ETF
FBND
|
+$2.39M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$839K |
| 4 |
First Trust Smith Unconstrained Bond ETF
UCON
|
+$789K |
| 5 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$750K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$3.86M |
| 2 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$909K |
| 3 |
NVIDIA
NVDA
|
+$367K |
| 4 |
Eli Lilly
LLY
|
+$191K |
| 5 |
Broadcom
AVGO
|
+$188K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.55% |
| 2 | Healthcare | 5.47% |
| 3 | Financials | 4.88% |
| 4 | Communication Services | 3.64% |
| 5 | Industrials | 3.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Allogene Therapeutics
ALLO
$694M
| $67.7K | 0.02% |
49,398
-10,467
| -17% | -$13.8K |
|
177
Public Storage
PSA
$61.3B
| $67.6K | 0.02% |
+260
| New | +$72.8K |
|
|
BNY
178
Bank of New York Mellon
BNY
$107B
| $66K | 0.02% |
+569
| New | +$63K |
|
179
Yum! Brands
YUM
$41.1B
| $66K | 0.02% |
+437
| New | +$64.7K |
|
180
Centene
CNC
$32.5B
| $65.4K | 0.02% |
+1,589
| New | +$59.5K |
|
181
Schwab US Large- Cap ETF
SCHX
$74.6B
| $64.7K | 0.02% |
+2,403
| New | +$64.2K |
|
182
Vanguard Morningstar Large-Cap ETF
VV
$54.5B
| $64.2K | 0.02% |
+204
| New | +$63.7K |
|
183
Enbridge
ENB
$112B
| $62K | 0.02% |
+1,297
| New | +$61.9K |
|
184
Applied Materials
AMAT
$428B
| $61.2K | 0.02% |
+238
| New | +$57.1K |
|
185
W.P. Carey
WPC
$16.4B
| $60.9K | 0.02% |
+947
| New | +$63.1K |
|
186
Target
TGT
$68B
| $60.9K | 0.02% |
+623
| New | +$57.4K |
|
187
Trane Technologies
TT
$106B
| $58.4K | 0.01% |
+150
| New | +$62K |
|
188
Vistra
VST
$47.4B
| $56.6K | 0.01% |
+351
| New | +$63.9K |
|
189
Philips
PHG
$26.1B
| $53.9K | 0.01% |
+2,063
| New | +$55K |
|
190
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.7B
| $51.9K | 0.01% |
+1,169
| New | +$51.1K |
|
191
iShares S&P Small-Cap 600 Value ETF
IJS
$8.37B
| $51.4K | 0.01% |
+452
| New | +$50.7K |
|
192
Moody's
MCO
$82.7B
| $51.1K | 0.01% |
+100
| New | +$48.8K |
|
193
Live Nation Entertainment
LYV
$42.1B
| $50.7K | 0.01% |
+356
| New | +$51.2K |
|
194
Manulife Financial
MFC
$73.5B
| $50.4K | 0.01% |
+1,388
| New | +$47.1K |
|
195
Chubb
CB
$135B
| $48.7K | 0.01% |
+156
| New | +$45.6K |
|
|
XYZ
196
Block Inc
XYZ
$47.5B
| $48.5K | 0.01% |
+745
| New | +$51.4K |
|
197
Vanguard Dividend Appreciation ETF
VIG
$114B
| $47.6K | 0.01% |
+217
| New | +$47.4K |
|
198
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $47.6K | 0.01% |
+390
| New | +$44.7K |
|
199
Consolidated Edison
ED
$39.9B
| $47K | 0.01% |
+473
| New | +$46.9K |
|
200
NewAmsterdam Pharma
NAMS
$3.34B
| $46.1K | 0.01% |
+1,315
| New | +$47.9K |
|
Similar funds
BP
LJAF
CSNH
OA
RCWVOTCITCONY
MAM
GPGA
WPW
Navalign LLC's Q4 2025 Portfolio in Review
As of Q4 2025, Navalign LLC held 512 positions worth $407M, up 7.5% from $379M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Navalign LLC deployed $21.5M of net new capital in Q4 2025, opening 387 new positions and adding to 60 existing holdings. Its largest new stake was JPMorgan US Quality Factor ETF: 120,844 shares worth $7.63M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Small-Cap ETF, an estimated $3.86M trimmed.
- Navalign LLC's largest Q4 2025 buy was JPMorgan US Quality Factor ETF: 120,844 shares worth $7.63M.
- Navalign LLC added most to Fidelity Total Bond ETF in Q4 2025, an estimated $2.39M increase.
- Navalign LLC's biggest Q4 2025 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $3.86M.
- Navalign LLC fully exited Cue Biopharma in Q4 2025, selling an estimated $18K.
- Navalign LLC's ten largest holdings make up 53% of its $407M portfolio in Q4 2025.
- Navalign LLC opened 387 new positions and closed 1 in Q4 2025.
- Navalign LLC's portfolio value rose 7.5% quarter-over-quarter to $407M.
Based on Navalign LLC's 13F filing for Q4 2025, filed 5 Feb 2026.